The software performs tumor segmentation and volumetric measurements, as well as generates imaging for 3D geometric analysis and longitudinal tracking of patients with high-grade glioma brain tumors, according to the vendor. These results can be used by physicians to plan procedures, evaluate postprocedural results, and guide chemotherapy and immunotherapy treatments, Neosoma said.